While STS inhibition prevented DHEAS-stimulated growth of MCF-7 breast cancer cells, an effect which was not reproduced by concurrent treatment with aromatase inhibitors [41], and serum DHEAS have been shown to be significantly higher in women who progressed on an AI [9]. This evidence concerns the gene STS and breast cancer.